However, germline genetic testing is now supported by NCCN guidelines for all men with high-risk, very-high-risk, regional or metastatic PCa as well as men with PCa who have Ashkenazi Jewish ancestry or family history of high-risk germline mutations (e.g. BRCA1/2, Lynch Syndrome). Here, BRCA1 is linked to posterior cortical atrophy.